Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Atopic Dermatitis Global Market Report 2025
Download Free Sample Buy Now
Global Atopic Dermatitis Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Atopic Dermatitis Global Market Report 2025

By Drug Class (Corticosteroids, Emollients/Moisturizers, IL-4 and PDE4 Inhibitors, Calcineurin Inhibitors, Antibiotics, Other Drug Classes), By Mode of Administration (Topical, Injectable, Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Atopic Dermatitis Market Overview

• Atopic Dermatitis market size has reached to $8.61 billion in 2024

• Expected to grow to $17.08 billion in 2029 at a compound annual growth rate (CAGR) of 14.7%

• Growth Driver: Rising Prevalence Of Atopic Dermatitis Is A Key Catalyst For The Growth Of The Atopic Dermatitis Market

• Market Trend: Product Innovations Transforms The Atopic Dermatitis Market

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Atopic Dermatitis Market?

Atopic dermatitis is a dermatological condition that causes dryness and itching of the skin. It is a chronic condition that progresses over time and is not spread by contact.

The main drug classes to treat atopic dermatitis include corticosteroids, emollients/moisturizers, IL-4 and PDE4 inhibitors, calcineurin inhibitors, antibiotics, and others. Corticosteroids refer to anti-inflammatory drugs that resemble cortisol and are used to treat a variety of diseases such as rheumatological diseases, rheumatoid arthritis, lupus, and atopic dermatitis. These are delivered through various modes of administration, including topical, injectable, and oral, and sold through several distribution channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

Atopic Dermatitis Market Size and growth rate 2025 to 2029: Graph

What Is The Atopic Dermatitis Market Size 2025 And Growth Rate?

The atopic dermatitis market size has grown rapidly in recent years. It will grow from $8.61 billion in 2024 to $9.88 billion in 2025 at a compound annual growth rate (CAGR) of 14.7%. The growth in the historic period can be attributed to medical understanding and awareness, incidence and prevalence rates, patient advocacy and support, treatment options evolution, research and development.

What Is The Atopic Dermatitis Market Growth Forecast?

The atopic dermatitis market size is expected to see rapid growth in the next few years. It will grow to $17.08 billion in 2029 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to biologic therapies advancements, immunomodulators and small molecule drugs, pediatric-specific treatments, gene therapy and precision medicine, digital health integration. Major trends in the forecast period include technological advancements in topicals, pediatric ad care focus, environmental and allergen management, precision diagnosis tools.

The forecast of 14.7% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. dermatology care by inflating prices of biologic treatments and therapeutic moisturizers developed in Denmark and France, resulting in prolonged flare-ups and higher specialty pharmacy expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Atopic Dermatitis Market Segmented?

1) By Drug Class: Corticosteroids, Emollients Or Moisturizers, IL-4 And PDE4 Inhibitors, Calcineurin Inhibitors, Antibiotics, Other Drug Classes

2) By Mode of Administration: Topical, Injectable, Oral

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Corticosteroids: Topical Corticosteroids, Systemic Corticosteroids

2) By Emollients Or Moisturizers: Creams and Lotions, Ointments and Balms, Barrier Repair Creams

3) By IL-4 And PDE4 Inhibitors: Dupilumab (IL-4 Inhibitor), Apremilast (PDE4 Inhibitor)

4) By Calcineurin Inhibitors: Tacrolimus Ointment, Pimecrolimus Cream

5) By Antibiotics: Topical Antibiotics, Systemic Antibiotics

6) By Other Drug Classes: Antihistamines, Biologics, JAK Inhibitors

What Is Driving The Atopic Dermatitis Market? Rising Prevalence Of Atopic Dermatitis Is A Key Catalyst For The Growth Of The Atopic Dermatitis Market

The high prevalence of atopic dermatitis is expected to propel the growth of the atopic dermatitis market forward. Atopic dermatitis, also called eczema, is a skin condition that causes dryness and itchiness of the skin. The increasing prevalence of atopic dermatitis increases the need for diagnosis and treatment of the disease. For instance, according to Oxford Academic, a UK-based publishing company, atopic dermatitis (AD) is widely prevalent across the globe, affecting approximately 2.6% of the world's population, equating to about 204 million people in 2024. This figure comprises about 101 million adults and 103 million children. Therefore, the increasing prevalence of atopic dermatitis is driving the growth of the atopic dermatitis industry.

What Is Driving The Atopic Dermatitis Market? Increasing Demand For Personalized Medicine Drives The Atopic Dermatitis Market

The increasing demand for personalized medicine is expected to propel the growth of the atopic dermatitis market going forward. Personalized medicine refers to an innovative approach to medical treatment and healthcare that tailors’ medical decisions, practices, interventions, and drug therapies to the individual patient. Personalized medicine in atopic dermatitis involves the identification of specific genetic and molecular factors influencing the disease, enabling the development of targeted therapies that address the unique characteristics of each patient. This approach not only enhances treatment efficacy but also minimizes adverse effects. For instance, in October 2022, according to reports published by STAT, a US-based health-oriented news company, there were more than 75,000 genetic testing products and 300 personalized medicines. Therefore, the increasing demand for personalized medicine is driving the growth of the atopic dermatitis industry.

Who Are The Major Players In The Global Atopic Dermatitis Market?

Major companies operating in the atopic dermatitis market are Sanofi SA, Meda AB, Regeneron Pharmaceuticals Inc., Novartis International AG, Pfizer Inc., AbbVie Inc., Astellas Pharma Inc., Arcutis Biotherapeutics Inc., Asana Biosciences LLC, Dermavant Sciences Inc., Eli Lilly and Company, Galderma SA, Incyte Corporation, Bayer AG, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline PLC, F Hoffmann-La Roche AG, LEO Pharma A/S, Teva Pharmaceutical Industries Ltd., Mylan MV, Allergan PLC, Encore Dermatology Inc., Menlo Therapeutics Inc., Johnson & Johnson, Merck & Co Inc., Roche Holding AG, Valeant Pharmaceuticals International Inc., Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Eisai Co. Ltd., Gilead Sciences Inc., Ipsen Biopharmaceuticals Inc., Kyowa Kirin Co. Ltd., Mallinckrodt Pharmaceuticals Limited

What Are The Key Trends Of The Global Atopic Dermatitis Market? Product Innovations Transforms The Atopic Dermatitis Market

Product innovations are a key trend gaining popularity in the atopic dermatitis market. Major companies in the market are introducing innovative products to strengthen their market position. For instance, in June 2022, Regeneron Pharmaceuticals Inc., a US-based biotechnology company received FDA approval for Dupixent (dupilumab). Dupixent is used for children with moderate-to-severe atopic dermatitis, ages 6 months to 5 years. Topical corticosteroids can be used with or without dupixent. Dupixent functions by inhibiting the signaling of two major Type 2 inflammatory sources (IL-4 and IL-13), which are crucial in the development of eosinophilic esophagitis, prurigo nodularis, chronic rhinosinusitis with nasal polyposis, and asthma.

What Are The Key Trends Of The Global Atopic Dermatitis Market? Increasing Focus On Product Approvals To Provide Reliable Services To Their Customers

Major companies operating in the atopic dermatitis market are focusing on product approvals to drive revenues in their market. Product approvals in atopic dermatitis represent the regulatory authorization granted to pharmaceuticals or treatments by health authorities, affirming their safety and efficacy for use in managing this inflammatory skin condition. For instance, in January 2022, AbbVie Inc., a US-based pharmaceutical company, received FDA approval for Rinvoq. Rinvoq (upadacitinib) is a medication used in the treatment of certain autoimmune conditions, particularly rheumatoid arthritis. Upadacitinib is a janus kinase (JAK) inhibitor, a type of targeted synthetic disease-modifying antirheumatic drug. Rinvoq (upadacitinib) is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and children 12 years of age and older when other medications or injections, including biologic medicines, have not been successful in controlling the disease or when using other medications or injections are not advised. Methotrexate and rinvoq can be administered together or separately as monotherapy.

Need data on a specific region in this market?
Request Regional Data

Atopic Dermatitis Market Merger And Acquisition: Arcutis Biotherapeutics Strengthens Position In Medical Dermatology Market Through Strategic Acquisition Of Ducentis Biotherapeutics

In September 2022, Arcutis Biotherapeutics, a US-based commercial-stage biopharmaceuticals company, acquired Ducentis BioTherapeutics for an undisclosed amount. The acquisition would help Arcutis achieve its vision of leading the medical dermatology market and would help it develop medications for the unmet dermatological needs of its patients. Ducentis BioTherapeutics is a US-based preclinical-stage biotechnology company developing lead indications for atopic dermatitis.

Regional Outlook For The Global Atopic Dermatitis Market

North America was the largest region in the atopic dermatitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Atopic Dermatitis Market?

The atopic dermatitis market consists of sales of biologics, CNI immunosuppressant drugs, and skin barrier emollients. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Atopic Dermatitis Industry?

The atopic dermatitis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the atopic dermatitis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Atopic Dermatitis Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $9.88 billion
Revenue Forecast In 2034 $17.08 billion
Growth Rate CAGR of 14.7% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Drug Class: Corticosteroids, Emollients Or Moisturizers, IL-4 And PDE4 Inhibitors, Calcineurin Inhibitors, Antibiotics, Other Drug Classes
2) By Mode of Administration: Topical, Injectable, Oral
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Corticosteroids: Topical Corticosteroids, Systemic Corticosteroids
2) By Emollients Or Moisturizers: Creams and Lotions, Ointments and Balms, Barrier Repair Creams
3) By IL-4 And PDE4 Inhibitors: Dupilumab (IL-4 Inhibitor), Apremilast (PDE4 Inhibitor)
4) By Calcineurin Inhibitors: Tacrolimus Ointment, Pimecrolimus Cream
5) By Antibiotics: Topical Antibiotics, Systemic Antibiotics 6) By Other Drug Classes: Antihistamines, Biologics, JAK Inhibitors
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Sanofi SA, Meda AB, Regeneron Pharmaceuticals Inc., Novartis International AG, Pfizer Inc., AbbVie Inc., Astellas Pharma Inc., Arcutis Biotherapeutics Inc., Asana Biosciences LLC, Dermavant Sciences Inc., Eli Lilly and Company, Galderma SA, Incyte Corporation, Bayer AG, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline PLC, F Hoffmann-La Roche AG, LEO Pharma A/S, Teva Pharmaceutical Industries Ltd., Mylan MV, Allergan PLC, Encore Dermatology Inc., Menlo Therapeutics Inc., Johnson & Johnson, Merck & Co Inc., Roche Holding AG, Valeant Pharmaceuticals International Inc., Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Eisai Co. Ltd., Gilead Sciences Inc., Ipsen Biopharmaceuticals Inc., Kyowa Kirin Co. Ltd., Mallinckrodt Pharmaceuticals Limited
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Atopic Dermatitis Market Characteristics

3. Atopic Dermatitis Market Trends And Strategies

4. Atopic Dermatitis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Atopic Dermatitis Growth Analysis And Strategic Analysis Framework

5.1. Global Atopic Dermatitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Atopic Dermatitis Market Growth Rate Analysis

5.4. Global Atopic Dermatitis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Atopic Dermatitis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Atopic Dermatitis Total Addressable Market (TAM)

6. Atopic Dermatitis Market Segmentation

6.1. Global Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Corticosteroids

Emollients/Moisturizers

IL-4 and PDE4 Inhibitors

Calcineurin Inhibitors

Antibiotics

Other Drug Classes

6.2. Global Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Topical

Injectable

Oral

6.3. Global Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

6.4. Global Atopic Dermatitis Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Topical Corticosteroids

Systemic Corticosteroids

6.5. Global Atopic Dermatitis Market, Sub-Segmentation Of Emollients Or Moisturizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Creams and Lotions

Ointments and Balms

Barrier Repair Creams

6.6. Global Atopic Dermatitis Market, Sub-Segmentation Of IL-4 And PDE4 Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Dupilumab (IL-4 Inhibitor)

Apremilast (PDE4 Inhibitor)

6.7. Global Atopic Dermatitis Market, Sub-Segmentation Of Calcineurin Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tacrolimus Ointment

Pimecrolimus Cream

6.8. Global Atopic Dermatitis Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Topical Antibiotics

Systemic Antibiotics

6.9. Global Atopic Dermatitis Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antihistamines

Biologics

JAK Inhibitors

7. Atopic Dermatitis Market Regional And Country Analysis

7.1. Global Atopic Dermatitis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Atopic Dermatitis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Atopic Dermatitis Market

8.1. Asia-Pacific Atopic Dermatitis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Atopic Dermatitis Market

9.1. China Atopic Dermatitis Market Overview

9.2. China Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Atopic Dermatitis Market

10.1. India Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Atopic Dermatitis Market

11.1. Japan Atopic Dermatitis Market Overview

11.2. Japan Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Atopic Dermatitis Market

12.1. Australia Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Atopic Dermatitis Market

13.1. Indonesia Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Atopic Dermatitis Market

14.1. South Korea Atopic Dermatitis Market Overview

14.2. South Korea Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Atopic Dermatitis Market

15.1. Western Europe Atopic Dermatitis Market Overview

15.2. Western Europe Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Atopic Dermatitis Market

16.1. UK Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Atopic Dermatitis Market

17.1. Germany Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Atopic Dermatitis Market

18.1. France Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Atopic Dermatitis Market

19.1. Italy Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Atopic Dermatitis Market

20.1. Spain Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Atopic Dermatitis Market

21.1. Eastern Europe Atopic Dermatitis Market Overview

21.2. Eastern Europe Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Atopic Dermatitis Market

22.1. Russia Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Atopic Dermatitis Market

23.1. North America Atopic Dermatitis Market Overview

23.2. North America Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Atopic Dermatitis Market

24.1. USA Atopic Dermatitis Market Overview

24.2. USA Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Atopic Dermatitis Market

25.1. Canada Atopic Dermatitis Market Overview

25.2. Canada Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Atopic Dermatitis Market

26.1. South America Atopic Dermatitis Market Overview

26.2. South America Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Atopic Dermatitis Market

27.1. Brazil Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Atopic Dermatitis Market

28.1. Middle East Atopic Dermatitis Market Overview

28.2. Middle East Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Atopic Dermatitis Market

29.1. Africa Atopic Dermatitis Market Overview

29.2. Africa Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Atopic Dermatitis Market Competitive Landscape And Company Profiles

30.1. Atopic Dermatitis Market Competitive Landscape

30.2. Atopic Dermatitis Market Company Profiles

30.2.1. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Meda AB Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Atopic Dermatitis Market Other Major And Innovative Companies

31.1. AbbVie Inc.

31.2. Astellas Pharma Inc.

31.3. Arcutis Biotherapeutics Inc.

31.4. Asana Biosciences LLC

31.5. Dermavant Sciences Inc.

31.6. Eli Lilly and Company

31.7. Galderma SA

31.8. Incyte Corporation

31.9. Bayer AG

31.10. Bausch Health Companies Inc.

31.11. Boehringer Ingelheim International GmbH

31.12. GlaxoSmithKline PLC

31.13. F Hoffmann-La Roche AG

31.14. LEO Pharma A/S

31.15. Teva Pharmaceutical Industries Ltd.

32. Global Atopic Dermatitis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Atopic Dermatitis Market

34. Recent Developments In The Atopic Dermatitis Market

35. Atopic Dermatitis Market High Potential Countries, Segments and Strategies

35.1 Atopic Dermatitis Market In 2029 - Countries Offering Most New Opportunities

35.2 Atopic Dermatitis Market In 2029 - Segments Offering Most New Opportunities

35.3 Atopic Dermatitis Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Atopic Dermatitis Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Atopic Dermatitis Market, Sub-Segmentation Of Emollients Or Moisturizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Atopic Dermatitis Market, Sub-Segmentation Of IL-4 And PDE4 Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Atopic Dermatitis Market, Sub-Segmentation Of Calcineurin Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Atopic Dermatitis Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Atopic Dermatitis Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Atopic Dermatitis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Atopic Dermatitis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Sanofi SA Financial Performance
  • Table 81: Meda AB Financial Performance
  • Table 82: Regeneron Pharmaceuticals Inc. Financial Performance
  • Table 83: Novartis International AG Financial Performance
  • Table 84: Pfizer Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Atopic Dermatitis Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Atopic Dermatitis Market, Sub-Segmentation Of Emollients Or Moisturizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Atopic Dermatitis Market, Sub-Segmentation Of IL-4 And PDE4 Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Atopic Dermatitis Market, Sub-Segmentation Of Calcineurin Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Atopic Dermatitis Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Atopic Dermatitis Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Atopic Dermatitis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Atopic Dermatitis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Sanofi SA Financial Performance
  • Figure 81: Meda AB Financial Performance
  • Figure 82: Regeneron Pharmaceuticals Inc. Financial Performance
  • Figure 83: Novartis International AG Financial Performance
  • Figure 84: Pfizer Inc. Financial Performance

Next-Gen Primary Immunodeficiency Disorders : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Primary Immunodeficiency Disorders : Market Forecast, Transformation, and Long-Term Trajectories

Proteus Syndrome Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Proteus Syndrome Growth Trajectory: Key Forecasts and Strategic Insights

Prothrombin Complex Concentrate Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Prothrombin Complex Concentrate Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prothrombin Complex Concentrate Market Landscape: Advanced Radiation Therapy Systems Enhancing Precision And Patient Outcomes

Read More About Emerging Trends Redefining the Prothrombin Complex Concentrate Market Landscape: Advanced Radiation Therapy Systems Enhancing Precision And Patient Outcomes

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Atopic Dermatitis Global Market Report 2025 – By Drug Class (Corticosteroids, Emollients/Moisturizers, IL-4 and PDE4 Inhibitors, Calcineurin Inhibitors, Antibiotics, Other Drug Classes), By Mode of Administration (Topica...

View Report

Dermatitis Global Market Report 2025 – By Drug Class (Corticosteroids, Emollients/Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics, Immunomodulators, Interleukin Inhibitors ), By Distribution Channel (Ho...

View Report

Dermatology Global Market Report 2025 – By Type (Medical Dermatology, Surgical Dermatology, Pediatric Dermatology, Cosmetic Dermatology, Cutaneous Lymphoma, Dermatoimmunology, Other Types ), By Application (Acne, Dermati...

View Report

Allergic Rhinitis Global Market Report 2025 – By Type (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis), By Treatment (Antihistamines, Corticosteroids, Immunotherapy, Decongestants...

View Report

Allergy Conjunctivitis Global Market Report 2025 – By Drug Class (Antihistamines and Mast Cell Stabilizers, Corticosteroids, Other Drug Classes), By Disease Type (Mild, Severe), By Distribution Channel (Hospital Pharmaci...

View Report

Seborrheic Dermatitis Global Market Report 2025 – By Treatment (Anti-Inflammatory, Antifungal, Corticosteroid Lotions, Sulfur Products, Other Treatments), By Diagnosis (Physical Examination, Biopsy, Other Diagnoses), By ...

View Report

Allergy Treatment Global Market Report 2025 – By Treatment Type (Anti-Allergy Drugs, Immunotherapy), By Type (Eye Allergy, Skin Allergy, Food Allergy, Asthma, Rhinitis, Other Types), By Route of Administration (Oral, Par...

View Report

Allergy Immunotherapy Global Market Report 2025 – By Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Other Allergy Types), By Treatment (Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, ...

View Report

Frequently Asked Questions

Atopic dermatitis is a dermatological condition that causes dryness and itching of the skin. It is a chronic condition that progresses over time and is not spread by contact. For further insights on this market, request a sample here

The market major growth driver - Rising Prevalence Of Atopic Dermatitis Is A Key Catalyst For The Growth Of The Atopic Dermatitis Market. For further insights on this market, request a sample here

The atopic dermatitis market size has grown rapidly in recent years. It will grow from $8.61 billion in 2024 to $9.88 billion in 2025 at a compound annual growth rate (CAGR) of 14.7%. The growth in the historic period can be attributed to medical understanding and awareness, incidence and prevalence rates, patient advocacy and support, treatment options evolution, research and development. The atopic dermatitis market size is expected to see rapid growth in the next few years. It will grow to " $17.08 billion in 2029 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to biologic therapies advancements, immunomodulators and small molecule drugs, pediatric-specific treatments, gene therapy and precision medicine, digital health integration. Major trends in the forecast period include technological advancements in topicals, pediatric ad care focus, environmental and allergen management, precision diagnosis tools. For further insights on this market, request a sample here

The atopic dermatitismarket covered in this report is segmented –
1) By Drug Class: Corticosteroids; Emollients Or Moisturizers; IL-4 And PDE4 Inhibitors; Calcineurin Inhibitors; Antibiotics; Other Drug Classes
2) By Mode of Administration: Topical; Injectable; Oral
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies Subsegments:
1) By Corticosteroids: Topical Corticosteroids; Systemic Corticosteroids
2) By Emollients Or Moisturizers: Creams and Lotions; Ointments and Balms; Barrier Repair Creams
3) By IL-4 And PDE4 Inhibitors: Dupilumab (IL-4 Inhibitor); Apremilast (PDE4 Inhibitor)
4) By Calcineurin Inhibitors: Tacrolimus Ointment; Pimecrolimus Cream
5) By Antibiotics: Topical Antibiotics; Systemic Antibiotics
6) By Other Drug Classes: Antihistamines; Biologics; JAK Inhibitors For further insights on this market, request a sample here

North America was the largest region in the atopic dermatitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atopic dermatitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the atopic dermatitis market are Sanofi SA, Meda AB, Regeneron Pharmaceuticals Inc., Novartis International AG, Pfizer Inc., AbbVie Inc., Astellas Pharma Inc., Arcutis Biotherapeutics Inc., Asana Biosciences LLC, Dermavant Sciences Inc., Eli Lilly and Company, Galderma SA, Incyte Corporation, Bayer AG, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline PLC, F Hoffmann-La Roche AG, LEO Pharma A/S, Teva Pharmaceutical Industries Ltd., Mylan MV, Allergan PLC, Encore Dermatology Inc., Menlo Therapeutics Inc., Johnson & Johnson, Merck & Co Inc., Roche Holding AG, Valeant Pharmaceuticals International Inc., Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Eisai Co. Ltd., Gilead Sciences Inc., Ipsen Biopharmaceuticals Inc., Kyowa Kirin Co. Ltd., Mallinckrodt Pharmaceuticals Limited . For further insights on this market, request a sample here.

Major trends in this market include Product Innovations Transforms The Atopic Dermatitis Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Atopic Dermatitis Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon